This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Medtech SA
Medtech SA, a prominent player in the medical technology sector, is headquartered in France and operates extensively across Europe. Founded in the early 2000s, the company has established itself as a leader in innovative healthcare solutions, focusing on advanced medical devices and diagnostic tools. Medtech SA is renowned for its cutting-edge products, which include state-of-the-art imaging systems and patient monitoring technologies, designed to enhance clinical outcomes and streamline healthcare processes. The company’s commitment to quality and innovation has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with leading healthcare institutions. With a focus on improving patient care and operational efficiency, Medtech SA continues to drive advancements in the medtech industry, making significant contributions to the future of healthcare.
DitchCarbon Score
How does Medtech SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medtech SA's score of 51 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medtech SA, headquartered in France, currently does not report specific carbon emissions data for the most recent year, as no absolute emissions figures are available. The company is a current subsidiary of Zimmer Biomet Holdings, Inc., and thus may inherit emissions data and climate commitments from its parent organisation. As part of its climate strategy, Medtech SA aligns with the sustainability initiatives of Zimmer Biomet Holdings, Inc., which includes commitments to Science-Based Targets Initiative (SBTi) and CDP reporting. However, specific reduction targets or achievements for Medtech SA have not been disclosed. The absence of direct emissions data highlights the importance of corporate responsibility in the medtech industry, where companies are increasingly expected to demonstrate transparency and commitment to reducing their carbon footprint. Medtech SA's climate commitments are likely influenced by the broader goals set by Zimmer Biomet, reflecting a growing trend in the sector towards sustainability and environmental stewardship.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | 00,000,000 |
| Scope 2 | - | - | - | - | - | - | - | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medtech SA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
